<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="364754">
  <stage>Registered</stage>
  <submitdate>9/08/2013</submitdate>
  <approvaldate>13/08/2013</approvaldate>
  <actrnumber>ACTRN12613000902796</actrnumber>
  <trial_identification>
    <studytitle>Palonosetron and aprepitant for prevention of postoperative nausea and vomiting in patient undergoing laparoscopic gynecology surgery.</studytitle>
    <scientifictitle>In patients undergoing laparoscopic gynecologic surgery, which is more effective for the prevention of postoperative nausea and vomiting between palonosetron and aprepitant.</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>None</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>postoperative nausea and vomiting in patients undergoing laparoscopic gynecologic surgery</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Anaesthetics</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>before 1 hour to induction of anesthesia aprepitant 40 mg was given to patients by oral</interventions>
    <comparator>palonosetron 0.075 mg was intravascular injected imediate after induction of anesthesia</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>severity of nausea assessed using 100 point-visual analogue scale(VAS)</outcome>
      <timepoint>at time of waking from anaesthesia 0hr, 2hr, 6hr, 24hr, 48hr</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>incidence of vomiting</outcome>
      <timepoint>at time of waking from anaesthesia 0hr, 2hr, 6hr, 24hr, 48hr</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>rescue antiemetics recorded by nurse</outcome>
      <timepoint>at time of waking from anaesthesia0hr, 2hr, 6hr, 24hr, 48hr</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>pain score assessed using 100 point-visual analogue scale</outcome>
      <timepoint>at time of waking from anaesthesia 0hr, 2hr, 6hr, 24hr, 48hr</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>fentanyl consumption recorded by nurse</outcome>
      <timepoint>at time of waking from anaesthesia 0hr, 2hr, 6hr, 24hr, 48hr</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>rescue analgeics recorded by nurse</outcome>
      <timepoint>at time of waking from anaesthesia 0hr, 2hr, 6hr, 24hr, 48hr</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>patients undergoing laparoscopic gynecologic surgery</inclusivecriteria>
    <inclusiveminage>20</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>60</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Pregnant women, 60 years of age or older and under 20 years old, weight 45kg or less, or more than 100kg,  more than American society of Anesthesiologist grade three , history of previous postoperative nausea and vomiting, history of motion sickness, smokers,  patient of serious cardiovascular system, kidney, liver, and hematological abnormalities.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1>True</masking1>
    <masking2>False</masking2>
    <masking3>True</masking3>
    <masking4>True</masking4>
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>1/10/2011</anticipatedstartdate>
    <actualstartdate>1/10/2011</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize>100</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Korea, Republic Of</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>Chung-ang university</primarysponsorname>
    <primarysponsoraddress>224-1 Heukseok-dong, Dongjak-gu Seoul, 156-755</primarysponsoraddress>
    <primarysponsorcountry>Korea, Republic Of</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>Chung-ang university</fundingname>
      <fundingaddress>224-1 Heukseok-dong, Dongjak-gu Seoul, 156-755</fundingaddress>
      <fundingcountry>Korea, Republic Of</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Postoperative nausea and vomiting (PONV) frequently develops in patients undergoing laparoscopic gynecologic surgery, The present study was undertaken to compare the effects of palanosetron and aprepitant on PONV in patients following laparoscopic gynecologic surgery. Patients were randomly assigned to one of two groups to receive antiemetics as follows: palanosetron 0.075 mg or aprepitant 40 mg. PONV, postoperative pain intensity, rescue antiemetics requirement, and side effects were assessed at 0, 2, 6,  24, 48 hr postoperatively.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Institutional Board of Chung-Ang University School of Medicine</ethicname>
      <ethicaddress>Chung-Ang University College of Medicine 224-1 Heukseok-dong, Dongjak-gu Seoul, 156-755, Korea </ethicaddress>
      <ethicapprovaldate>7/09/2011</ethicapprovaldate>
      <hrec>C2011088(538)</hrec>
      <ethicsubmitdate />
      <ethiccountry>Korea, Republic Of</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Prof</title>
      <name>Chongwha Baek</name>
      <address>Department of Anaesthesiology and Pain Medicine Chung-Ang University College of Medicine 224-1 Heukseok-dong, Dongjak-gu Seoul, 156-755, Korea </address>
      <phone>+82-2-6299-2579</phone>
      <fax>+82-2-6299-2585</fax>
      <email>nbjhwa@naver.com</email>
      <country>Korea, Republic Of</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Chongwha Baek</name>
      <address>Department of Anaesthesiology and Pain Medicine Chung-Ang University College of Medicine 224-1 Heukseok-dong, Dongjak-gu Seoul, 156-755, Korea </address>
      <phone>+82-2-6299-2579</phone>
      <fax>+82-2-6299-2585</fax>
      <email>nbjhwa@naver.com</email>
      <country>Korea, Republic Of</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Chongwha Baek</name>
      <address>Department of Anaesthesiology and Pain Medicine Chung-Ang University College of Medicine 224-1 Heukseok-dong, Dongjak-gu Seoul, 156-755, Korea </address>
      <phone>+82-2-6299-2579</phone>
      <fax>+82-2-6299-2585</fax>
      <email>nbjhwa@naver.com</email>
      <country>Korea, Republic Of</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>